Log in to save to my catalogue

Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP)

Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP)

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1896411007

Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP)

About this item

Full title

Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP)

Publisher

New York: Springer US

Journal title

Neurochemical research, 2017-07, Vol.42 (7), p.1939-1948

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Cannabidiol (CBD) is a cannabinoid component of marijuana that has no significant activity at cannabinoid receptors or psychoactive effects. There is considerable interest in CBD as a therapy for epilepsy. Almost a third of epilepsy patients are not adequately controlled by clinically available anti-seizure drugs (ASDs). Initial studies appear to d...

Alternative Titles

Full title

Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1896411007

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1896411007

Other Identifiers

ISSN

0364-3190

E-ISSN

1573-6903

DOI

10.1007/s11064-017-2287-8

How to access this item